North American Society for Interventional Thyroidology (NASIT) Statement on the Use of Embolization for the Management of Thyroid Disease
Methodological detailsexpert consensus, multidisciplinary expert review of the literature
- Expert consensus
- Multidisciplinary expert review of the literature
Recommendations
As issued by the authors
Thyroid artery embolization (TAE) is particularly effective for large-volume thyroid disease (>30 mL nodules and >50 mL goiters) and substernal extension: 32% to 73% volume reduction at 6 months, with improved compressive symptoms and cosmesis
In GD and toxic multinodular goiter, euthyroidism rates exceed 70%, with reported durability up to 50 months
Preoperative TAE may reduce operative time and blood loss
Most adverse events are mild and self-limited; serious complications are rare
Original publication
North American Society for Interventional Thyroidology (NASIT) Statement on the Use of Embolization for the Management of Thyroid Disease. Endocr Pract. Published 14 August 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →